Company research / VYGR
Voyager Therapeutics, Inc. (VYGR)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Voyager Therapeutics, Inc. reported revenue of $40.37M. Revenue fell 49.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $34.46M.
Key ratios (year ended 2025-12-31)
-326.6%
Operating margin
-296.5%
Net margin
-61.1%
Return on year-end equity
-49.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.